|
| |
 |
 |
 |
 |
| |
|
|
| |
| Members in the News - June 2008 |
| |
 |
| |
Date: June 5, 2008
Subject: Member in the News: Nicholas Barker, The GI Company, reports successful Phase II trials with drug to help fight cancer. |
| |
| Nicholas (Nick) Barker, CEO of The GI Company, recently presented the results of its Phase II clinical study for its Intestinal Trefoil Factor drug to the American Society of Clinical Oncology (ASCO). |
| |
| Read More |
| |
|
| |
Date: June 12, 2008
Subject: Member in the News: Mark Leuchtenberger, Targanta Therapeutics, files in Europe for its lead drug. |
| |
| Mark Leuchtenberger, CEO of Targanta Therapeutics, reported that the company has filed an application with the EMA in Europe to seek approval of its experimental antibiotic oritavancin as a treatment for complicated skin and soft-tissue infections caused by certain bacteria, such as deadly MRSA. |
| |
| Read More |
| |
|
| |
Date: June 25, 2008
Subject: Member in the News: Mark Leuchtenberger, Targanta Therapeutics, featured in Boston Busines. |
| |
| Mark Leuchtenberger, CEO of Targanta Therapeutics, is featured in the "Executive Profile" section of Boston Business Journal, June 20-26, page 3. This profile, written by Mark Hollmer, and the photo of Mark preparing to windsurf do a very good job of portraying the guy we know. |
| |
| Read More |
| |
|
| |
|
|
|
